Cited by 1,585Atrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studiesHeart Failure Treatment and Management

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure

Roy, Denis, Talajic, Mario, Nattel, Stanley, Wyse, D. George, Dorian, Paul, Lee, Kerry L., Bourassa, Martial G., Arnold, J. Malcolm O., Buxton, Alfred E., Camm, A. John, Connolly, Stuart J., Dubuc, Marc, Ducharme, Anique, Guerra, Peter G., Hohnloser, Stefan H., Lambert, Jean, Le Heuzey, Jean-Yves, O'Hara, Gilles, Pedersen, Ole Dyg, Rouleau, Jean-Lucien, Singh, Bramah N., Stevenson, Lynne Warner, Stevenson, William G., Thibault, Bernard, Waldo, Albert L.·2008·New England Journal of Medicine

DOI 10.1056/nejmoa0708789

Open this paper in CoChat — free account

Abstract

BACKGROUND: It is common practice to restore and maintain sinus rhythm in patients with atrial fibrillation and heart failure. This approach is based in part on data indicating that atrial fibrillation is a predictor of death in patients with heart failure and suggesting that the suppression of atrial fibrillation may favorably affect the outcome. However, the benefits and risks of this approach have not been adequately studied. METHODS: We conducted a multicenter, randomized trial comparing the maintenance of sinus rhythm (rhythm control) with control of the ventricular rate (rate control) in patients with a left ventricular ejection fraction of 35% or less, symptoms of congestive heart failure, and a history of atrial fibrillation. The primary outcome was the time to death from cardiovascular causes. RESULTS: A total of 1376 patients were enrolled (682 in the rhythm-control group and 694 in the rate-control group) and were followed for a mean of 37 months. Of these patients, 182 (27%) in the rhythm-control group died from cardiovascular causes, as compared with 175 (25%) in the rate-control group (hazard ratio in the rhythm-control group, 1.06; 95% confidence interval, 0.86 to 1.30; P=0.59 by the log-rank test). Secondary outcomes were similar in the two groups, including death from any cause (32% in the rhythm-control group and 33% in the rate-control group), stroke (3% and 4%, respectively), worsening heart failure (28% and 31%), and the composite of death from cardiovascular causes, stroke, or worsening heart failure (43% and 46%). There were also no significant differences favoring either strategy in any predefined subgroup. CONCLUSIONS: In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy. (ClinicalTrials.gov number, NCT00597077.)

Integrity signals

Registry

Crossref · 10.1056/nejmoa0708789

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citation
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
Gelder, I. C. V., Hagens, V. E., Bosker, H. A., Kingma, J. H., Otto Kamp, B., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,355
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,282
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study
Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J. (2003) · Circulation · doi:10.1161/01.cir.0000072767.89944.6e · Cited by 1,970
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426

Show all 41 references

Research works printed but not linked: 1

Carson PE, 1993, Circulation, 87, VI

Sorted by citations

Items 701–800 of 999

Treating arrhythmias: an expert opinion
Dagres, N., Sommer, P., ANASTASIOU‐NANA, M. I., & Hindricks, G. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.555397 · Cited by 9
Is rate more important than rhythm in treating atrial fibrillation? No
Mitchell, A. R. J. (2009) · BMJ · doi:10.1136/bmj.b3174 · Cited by 8
Atrial Fibrillation: Antiarrhythmic Therapy
Psotka, M. A., & Lee, B. K. (2014) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2014.07.004 · Cited by 9
Pharmacological Management of Atrial Fibrillation: One, None, One Hundred Thousand
Lucà, F., Meir, M. L., Rao, C. M., Parise, O., Vasquez, L., Carella, R., Lorusso, R., Daniela, B., Maessen, J. G., Gensini, G. F., et al. (2011) · Cardiology Research and Practice · doi:10.4061/2011/874802 · Cited by 9
Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation
Roberts, J. D., Dewland, T. A., Glidden, D. V., Hoffmann, T. J., Arking, D. E., Chen, L. Y., Psaty, B. M., Olgin, J. E., Alonso, Á., Heckbert, S. R., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.02.002 · Cited by 9
Impaired quality of life in patients with intermittent atrial fibrillation
Nazlı, C., Eren, N. K., Tülüce, S. Y., Yağız, İ. G. K., Kılıçaslan, B., & Kocabaş, U. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2015.6144 · Cited by 9
Pharmacological Therapy for Rate and Rhythm Control for Atrial Fibrillation in 2017
Kanagaratnam, L. B., Kowey, P. R., & Whalley, D. W. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.134 · Cited by 10
Catheter ablation of atrial fibrillation—A key role in heart failure therapy?
Paiva, B. T. C., Fischer, T., Brachmann, J., & Busch, S. (2019) · Clinical Cardiology · doi:10.1002/clc.23150 · Cited by 8
Temporal trends in the availability and efficacy of catheter ablation for atrial fibrillation and atrial flutter in a highly populated urban area
Faryan, M., Buchta, P., Kowalski, O., Wybraniec, M. T., Cieśla, D., Myrda, K., Wnuk-Wojnar, A. M., Kalarus, Z. F., Gąsior, M., & Mizia‐Stec, K. (2020) · Kardiologia Polska · doi:10.33963/kp.15275 · Cited by 9
Management of tachyarrhythmias in pregnancy – A review
Kugamoorthy, P., & SPEARS, D. A. (2020) · Obstetric Medicine · doi:10.1177/1753495x20913448 · Cited by 9
Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community‐based study
Zhang, P., Chamberlain, A. M., Hodge, D. O., Cai, C., Xiao, P., Han, J., Jiang, C., Redfield, M. M., Roger, V. L., & Cha, Y. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14632 · Cited by 9
Rhythm Control in Heart Failure Patients with Atrial Fibrillation
Eysenck, W., & SABA, M. M. (2020) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2020.23 · Cited by 9
Management und Therapie des Vorhofflimmerns beim geriatrischen Patienten
Gosch, M., Roller, R. E., Böhmdorfer, B., Benvenuti-Falger, U., Iglseder, B., Lechleitner, M., Sommeregger, U., & Dovjak, P. (2012) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-011-0268-0 · Cited by 8
Rate versus rhythm control in atrial fibrillation.
Frankel, G., Kamrul, R., Kosar, L., & Jensen, B. (2013) · Europe PMC (PubMed Central) · Cited by 9
Update on medical management of atrial fibrillation in the modern era
Gopinathannair, R., Sullivan, R. M., & Olshansky, B. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.02.013 · Cited by 8
Pulmonary vein isolation of symptomatic refractory paroxysmal and persistent atrial fibrillation
Tan, E. S., Mulder, B. A., Rienstra, M., Wiesfeld, A. C. P., Ahmed, S., Zijlstra, F., & Gelder, I. C. V. (2009) · Netherlands Heart Journal · doi:10.1007/bf03086286 · Cited by 9
Calidad de vida en pacientes con fibrilación auricular
Camm, A. J. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70263-3 · Cited by 9
New Therapies for Stroke Prevention in Atrial Fibrillation
Freedman, J. E., & Gersh, B. J. (2009) · Circulation · doi:10.1161/circulationaha.109.893362 · Cited by 9
Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024)
Tereshchenko, S. N., Жиров, И. В., Uskach, T. M., Saidova, M. A., Sp, G., Rimskaya, E. M., Николаевна, Н. С., Narusov, O. Y., Safiullina, A. A., Tereshchenko, A. S., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-2-6-76 · Cited by 8
Sodium Glucose Cotransporter 2 Inhibitors Improve Long-term Atrial Fibrillation-free Survival After Catheter Ablation
Hakgör, A., Olgun, F. E., Dursun, A., Kahraman, B. C., Akhundova, A., Savur, Ü., Besiroglu, M., Kenger, M. Z., Derviş, E., Şengör, B. G., et al. (2024) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001656 · Cited by 8
Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction
Boehmer, A. A., Ehrlich, J. R., & Nattel, S. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.09.014 · Cited by 10
What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation?
Velu, S., & Lip, G. Y. H. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0091-9 · Cited by 8
Rotors and Focal Sources for Human Atrial Fibrillation
Lalani, G., Trikha, R., Krummen, D. E., & Narayan, S. M. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0478 · Cited by 8
Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies
Lacoste, J. L., Szymanski, T. W., Avalon, J. C., Kabulski, G. M., Kohli, U., Marrouche, N. F., Singla, A., Balla, S., & Jahangir, A. (2022) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-022-00529-6 · Cited by 8
Kommentar zu den Leitlinien der ESC zum Vorhofflimmern
Kirchhof, P. F., Goette, A., Gulba, D. C., Hindricks, G., & Hohnloser, S. H. (2012) · Der Kardiologe · doi:10.1007/s12181-011-0395-2 · Cited by 8
Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study
Potpara, T., Polovina, M. M., Mujović, N. M., Kocijančić, A., & Lip, G. Y. H. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s50990 · Cited by 8
Atrial Fibrillation Management Strategies in Routine Clinical Practice: Insights from the International RealiseAF Survey
Chiang, C., Naditch‐Brûlé, L., Brette, S., Silva‐Cardoso, J., Gamra, H., Murín, J., Zharinov, O. J., & Steg, P. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147536 · Cited by 8
Atrial fibrillation with a structurally normal heart in pregnancy: An international survey on current practice
Cumyn, A., Sauvé, N., & Rey, É. (2017) · Obstetric Medicine · doi:10.1177/1753495x16685684 · Cited by 8
Electrocardiographic intervals associated with incident atrial fibrillation: Dissecting the QT interval
Roberts, J. D., Soliman, E. Z., Alonso, Á., Vittinghoff, E., Chen, L. Y., Loehr, L. R., & Marcus, G. M. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.02.005 · Cited by 8
Antiarrhythmic drug therapy among patients presenting to emergency department with symptomatic atrial fibrillation – a prospective nationwide cohort
for the FinFib2 investigators, Penttilä, T., Mäkynen, H., Hartikainen, J. E. K., Hyppölä, H. T., Lauri, T., Lehto, M., Lund, J., & Raatikainen, M. J. P. (2017) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/s13049-017-0424-7 · Cited by 8
Renalase is associated with adverse left atrial remodelling and disease burden in patients with atrial fibrillation undergoing pulmonary vein isolation
Wybraniec, M. T., Wieczorek, J., Wozniak‐Skowerska, I., Hoffmann, A., Nowak, S., Cichoń, M., Szydło, K., Wnuk-Wojnar, A. M., Chudek, J. T., Więcek, A., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.a2018.0108 · Cited by 8
β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
Xu, T., Huang, Y., Zhou, H., Bai, Y., Huang, X., Hu, Y., Xu, D., Zhang, Y., & Zhang, J. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1079-2 · Cited by 8
Influence of heart rate control on exercise capacity and quality of life in patients with permanent atrial fibrillation
She, F., Ma, Y., Li, Y., Li, L., Xu, W., Wang, H., & Cui, M. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-01293-3 · Cited by 8
Current pharmacotherapeutic strategies for cardiac arrhythmias in heart failure
Correa, A. A., Rochlani, Y. M., & Aronow, W. S. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1703950 · Cited by 8
Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure
Samuel, M., Abrahamowicz, M., Joza, J. E., Essebag, V., & Pilote, L. (2020) · CJC Open · doi:10.1016/j.cjco.2020.01.004 · Cited by 8
A Comparison of Rate Control Agents for the Treatment of Atrial Fibrillation: Follow-Up Investigation of the AFFIRM Study
Zaman, N., Naccarelli, G. V., & Foy, A. (2021) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420987451 · Cited by 9
Sex Difference in Effectiveness of Early Rhythm- over Rate-Control in Patients with Atrial Fibrillation
Kang, D., Kim, D., Jang, E., Yu, H. T., Kim, T., Pak, H., Sung, J., Lee, M., Yang, P., & Joung, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11174991 · Cited by 8
Heart Failure in Patients with Atrial Fibrillation: Insights from Polish part of the EORP-AF General Long-Term Registry
Budnik, M., Gawalko, M. M., Lodziński, P., Tymińska, A., Ozierański, K., Grabowski, M., Peller, M., Wancerz, A., Kiliszek, M., Opolski, G., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14130 · Cited by 8
Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction
Schupp, T., Schmitt, A., Reinhardt, M., Abel, N., Lau, F., Abumayyaleh, M., Dudda, J., Weidner, K., Ayoub, M., Akin, M., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae185 · Cited by 8
New Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation
Schmitt, J., Ehrlich, J. R., & Hohnloser, S. H. (2008) · Herz · doi:10.1007/s00059-008-3151-z · Cited by 8
Treatment Failure With Rhythm and Rate Control Strategies in Patients With Atrial Fibrillation and Congestive Heart Failure: An AF‐CHF Substudy
Dyrda, K., Roy, D., Leduc, H., Talajic, M. R., Stevenson, L. W., Guerra, P. G., Andrade, J. G., Dubuc, M., Macle, L., Thibault, B., et al. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12828 · Cited by 8
Estudo transversal das estratégias de tratamento clínico na fibrilação atrial
Oliveira, L. H., Mallmann, F. B., Botelho, F. N., Paul, L. C., Gianotto, M., Abt, R. D. B., da Silva, N. J. C., Luize, C. M., Nogueira, F. L., de Carvalho, R. S., et al. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2012005000020 · Cited by 8
Does Chronic Atrial Fibrillation Induce Cardiac Remodeling?
Fuchs, T. T., Baron, E. L., Leitman, M., Burgsdorf, O., Torjman, A., & Vered, Z. (2012) · Echocardiography · doi:10.1111/echo.12003 · Cited by 8
Advances in Prevention and Health Services Delivery 2009
Goldstein, L. B., & Rothwell, P. M. (2010) · Stroke · doi:10.1161/strokeaha.109.570531 · Cited by 8
Pharmacological therapy for atrial fibrillation: current options and new agents
Viswanathan, M. N., & Page, R. L. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902773410 · Cited by 8
Drug Therapy for Atrial Fibrillation
Conway, E. L., Musco, S., & Kowey, P. R. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.10.003 · Cited by 8
Safety and efficacy of external electrical cardioversion in patients with left ventricular leads
Lüker, J., Bodman, G. V., Sultan, A., Brömsen, J., Akbulak, R. Ö., Schäffer, B., Schreiber, D., Hoffmann, B. A., Block, M. S., Willems, S., et al. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0800-5 · Cited by 8
Atrial fibrillation in heart failure: catheter and surgical interventional therapies
Rabah, A., & Wazni, O. M. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9411-x · Cited by 8
Atrial Fibrillation in Heart Failure: An Innocent Bystander?
Khan, M. A., Neyses, L., & Mamas, M. A. (2012) · Current Cardiology Reviews · doi:10.2174/157340312803760839 · Cited by 8
Predictive value of the heart rate reserve in patients with permanent atrial fibrillation treated according to a strict rate-control strategy
Schryver, N. D., Scavée, C., Marchandise, S., Pasquet, A., de Meester, C., & de Waroux, J. L. P. (2014) · EP Europace · doi:10.1093/europace/euu033 · Cited by 8
Trends in outpatient anti‐arrhythmic prescriptions for atrial fibrillation and left atrial ablation in Australia: 1997–2016
Khan, I., Patel, H. C., Nanayakkara, S., Raju, H., Voskoboinik, A., & Mariani, J. A. (2017) · Internal Medicine Journal · doi:10.1111/imj.13706 · Cited by 8
Fibrilace síní
Cihak, R. J., Heinc, P., Haman, L., Fiala, M., Neužil, P., & Toman, O. (2011) · Cor et Vasa · doi:10.33678/cor.2011.193 · Cited by 8
Effectiveness of catheter ablation of atrial fibrillation according to heart failure etiology
Black‐Maier, E., Steinberg, B. A., Trulock, K. M., Wang, F. M., Lokhnygina, Y. V., O’Neal, W. K., Al‐Khatib, S. M., Atwater, B. D., Daubert, J. P., Frazier‐Mills, C. G., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12291 · Cited by 7
Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone
Krishnamoorthy, S., & Lip, G. Y. H. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.14 · Cited by 8
Rhythm Control versus Rate Control for Atrial Fibrillation
Knecht, S., O'Neill, M. D., & Verbeet, T. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmc081487 · Cited by 8
Nuevas perspectivas farmacológicas en pacientes con fibrilación auricular: el ensayo ATHENA
Hohnloser, S. H. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)71027-9 · Cited by 8
It is time for catheter ablation to be considered a first-line treatment option in patients with atrial fibrillation and heart failure
Kheirkhahan, M., & MARROUCHE, N. F. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.02.009 · Cited by 8
Eurasian clinical guidelines for the diagnosis and treatment of atrial fibrillation in adult patients (2025)
Sp, G., Панченко, Е. П., Mironov, N. Y., Михайловна, Б. М., Gagloeva, D. A., Elfimova, E. M., Станиславовна, К. Е., Laiovich, L. I., Litvin, A. Y., Maykov, E. B., et al. (2025) · Eurasian heart journal · doi:10.38109/2225-1685-2025-3-6-77 · Cited by 8
Atrial Fibrillation in the Aging Heart: Pharmacological Therapy and Catheter Ablation in the Elderly
Haegeli, L., & Duru, F. (2011) · Future Cardiology · doi:10.2217/fca.11.22 · Cited by 7
Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation
Pallisgaard, J. L., Hansen, M. L., Schjerning, A.-M., Johannessen, A. C., Gerds, T. A., Gustafsson, F., Gislason, G., Torp-Pedersen, C., Jacobsen, P. K., Kristensen, S. L., et al. (2020) · Open Heart · doi:10.1136/openhrt-2020-001369 · Cited by 7
Antiarrhythmic Treatment in Heart Failure
Könemann, H., Güler-Eren, S., Ellermann, C., Frommeyer, G., & Eckardt, L. (2024) · Current Heart Failure Reports · doi:10.1007/s11897-023-00642-w · Cited by 7
Ventricular arrhythmias after atrial fibrillation electrical cardioversion: A multicenter study
Tovia‐Brodie, O., Michowitz, Y., Bayya, F., Havránek, Š., Dusík, M., Rivetti, L., Mantovan, R., Sabbag, A., Massalha, E., Lazzerini, P. E., et al. (2024) · Heart Rhythm O2 · doi:10.1016/j.hroo.2024.08.009 · Cited by 7
Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Can we Break the Vicious Circle?
Anselmino, M., Matta, M., & Gaïta, F. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.411 · Cited by 7
A comparison between monophasic and biphasic defibrillation for the cardioversion of persistent atrial fibrillation in patients with and without heart failure
Shelton, R. J., Brown, B. D., Allinson, A., Johnson, T., Smales, C., Jolly, S., & Cleland, J. G. F. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.09.545 · Cited by 7
The Year in Review of Clinical Cardiac Electrophysiology
Marcus, G. M., Keung, E. C., & Scheinman, M. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.062 · Cited by 7
Management of atrial fibrillation
Vergara, P., & Bella, P. E. D. (2014) · F1000Prime Reports · doi:10.12703/p6-22 · Cited by 7
A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
Iyngkaran, P., Toukhsati, S. R., Thomas, M. C., Jelinek, M. V., Hare, D. L., & Horowitz, J. D. (2016) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s38444 · Cited by 7
Atrial Fibrillation in Heart Failure—Diagnostic, Therapeutic, and Prognostic Relevance
Stegmann, C., & Hindricks, G. (2019) · Current Heart Failure Reports · doi:10.1007/s11897-019-00430-5 · Cited by 7
Atrioventricular junctional ablation: The good, the bad, the better
Scherlag, B. J., Elkholey, K., Stavrakis, S., Jackman, W. M., & Po, S. S. (2020) · Heart Rhythm O2 · doi:10.1016/j.hroo.2020.06.003 · Cited by 7
Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.
Koniari, I. C., Artopoulou, E., Velissaris, D., Kounis, N. G., & Tsigkas, G. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.05.003 · Cited by 8
Very early versus early referral for ablation in young patients with newly diagnosed paroxysmal atrial fibrillation
D’Angelo, R. N., Khanna, R., Wong, C., Yeh, R. W., Goldstein, L. J., Marcello, S. R., Tung, P., d’Ávila, A., & ZIMETBAUM, P. J. (2022) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14459 · Cited by 7
New and emerging antiarrhythmic drugs for atrial fibrillation: What may become available to the clinician in the near future
Kumar, K., & ZIMETBAUM, P. J. (2009) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-009-0038-0 · Cited by 7
Fibrillation atriale, description de la prise en charge par les cardiologues, étude observationnelle. Résultats de l’étude Factuel
Mabo, P., Leenhardt, A., Jaillon, P., Kacet, S., Aubin, F., Denjoy, I., & Heuzey, J. Y. L. (2009) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2009.01.002 · Cited by 7
Present concepts in management of atrial fibrillation: From drug therapy to ablation
Forleo, G. B. (2009) · World Journal of Cardiology · doi:10.4330/wjc.v1.i1.11 · Cited by 7
Improvement of the myocardial performance index in atrial fibrilation patients treated with amiodarone after cardioversion
Beşli, F., Başar, C., Keçebaş, M., & Türker, Y. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9965-0 · Cited by 7
Diagnosis and Management of Atrial Fibrillation: An Overview
Romero, I., Nedios, S., & Kriatselis, C. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12090 · Cited by 7
Pharmacotherapeutic decision-making for patients with atrial fibrillation
Kalus, J. S. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100149 · Cited by 7
Rate Control Is a Better Initial Treatment for Patients With Atrial Fibrillation and Heart Failure - Rhythm Control vs. Rate Control: Which Is Better in the Management of Atrial Fibrillation? (Rate-Side) -
Chinushi, M., & Iijima, K. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0080 · Cited by 7
Cardiac Arrhythmias with Supraventricular Origin
ZIMETBAUM, P. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00064-6 · Cited by 7
Biomarkers in Persistent AF and Heart Failure: Impact of Catheter Ablation Compared with Rate Control
Jones, D. G., Haldar, S., Donovan, J., McDonagh, T. A., Sharma, R. K., Hussain, W., Markides, V., & Wong, T. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12919 · Cited by 7
Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry
An, Y., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., Tsuji, H., Wada, H., Hasegawa, K., Ogawa, H., Abe, M., et al. (2018) · Heart and Vessels · doi:10.1007/s00380-018-1194-5 · Cited by 7
The impact of catheter ablation for atrial fibrillation in heart failure
Moschonas, K., Nabeebaccus, A., Okonko, D. O., McDonagh, T. A., MURGATROYD, F. D., Dhillon, P., & Scott, P. A. (2018) · Journal of Arrhythmia · doi:10.1002/joa3.12115 · Cited by 7
Pharmacological management of atrial fibrillation in patients with heart failure with reduced ejection fraction: review of current knowledge and future directions
Grubb, A. F., & Mentz, R. J. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1732210 · Cited by 10
Deciphering the fundamental mechanisms of atrial fibrillation: a quest for over a century
Nattel, S., & Dobrev, D. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw028 · Cited by 7
Atrial Fibrillation and Atrial Flutter
Chen, J. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.08.002 · Cited by 7
Effectiveness of catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation
NOVAK, P. G. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32831c52e6 · Cited by 7
Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy
Sterling, J. A. (2007) · Hospital Pharmacy · doi:10.1310/hpj4206-578 · Cited by 7
Left atrial ablation for management of atrial fibrillation: CABANA vs. real-world data. Apples and oranges?
Camm, A. J. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz168 · Cited by 7
Burden of atrial fibrillation among adults with heart failure in sub-Saharan Africa: a systematic review and meta-analysis
Agbor, V. N., Tianyi, F.-L., Aminde, L. N., Mbanga, C. M., Petnga, S.-J. N., Simo, L. P., Dzudié, A., Chobufo, M. D., & Noubiap, J. J. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061618 · Cited by 6
Dronedarone Therapy in Atrial Fibrillation: A Summary of Recent Controlled Trials
Duray, G. Z., Schmitt, J., & Hohnloser, S. H. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410368530 · Cited by 6
The Optimal Management of Patients with Atrial Fibrillation and Acute Heart Failure in the Emergency Department
Velliou, M., Sanidas, E. A., Diakantonis, A., Ventoulis, I., Parissis, J., & Polyzogopoulou, E. (2023) · Medicina · doi:10.3390/medicina59122113 · Cited by 6
Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
Chinese Society of Cardiology, C. M. A., & Heart Rhythm Committee of Chinese Society of Biomedical Engineering (2024) · Cardiology Discovery · doi:10.1097/cd9.0000000000000123 · Cited by 7
Long-term impact of atrial fibrillation catheter ablation on heart failure with preserved ejection fraction
Patel, H. D., Munshi, R., Sheth, A. R., Agarwal, S., Munoz, F. D., Kowlgi, G. N., DeSimone, C. V., Labedi, M. R., Dani, S. S., & Deshmukh, A. J. (2024) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-024-01939-z · Cited by 6
Preventing Thrombosis to Improve Outcomes in Heart Failure Patients
Shantsila, E., & Lip, G. Y. H. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.09.005 · Cited by 6
Atrial Fibrillation in Heart Failure in the Older Population
Heck, P. M., Lee, J., & Kistler, P. M. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.007 · Cited by 6
Current management of atrial fibrillation
Samardhi, H., Santos, M. J., Denman, R. A., Walters, D., & Bett, N. (2011) · Australian Prescriber · doi:10.18773/austprescr.2011.058 · Cited by 6
Atrial Fibrillation in Patients with Heart Failure: Current State and Future Directions
Mene-Afejuku, T. O., Lopez, P. D., Akinlonu, A. A., Dumancas, C. Y., Visco, F., Mushiyev, S., & Pekler, G. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0276-1 · Cited by 6
Single‐center experience of the FIRM technique to ablate paroxysmal and persistent atrial fibrillation
Henley, P., Foreman, J. R., Padanilam, B. J., Nair, G. V., Olson, J., Joshi, S. A., Aziz, Z. A., Foster, T., & Prystowsky, E. N. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13832 · Cited by 6
Current Management Strategies in Patients with Heart Failure and Atrial Fibrillation: A Review of the Literature
Parker, A. M., Vilaro, J. R., Ahmed, M. M., & Aranda, J. M. (2020) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2019.0595 · Cited by 6
Rapid Atrial Fibrillation in the Emergency Department
Alsagaff, M. Y., Susilo, H., Pramudia, C., Juzar, D. A., Amadis, M. R., Julario, R., Raharjo, S. B., Dharmadjati, B. B., Lusida, T. T. E., Azmi, Y., et al. (2022) · Heart International · doi:10.17925/hi.2022.16.1.12 · Cited by 6

Authors: Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., Connolly, S. J., Dubuc, M., Ducharme, A., Guerra, P. G., Hohnloser, S. H., Lambert, J., Le Heuzey, J.-Y., O'Hara, G., Pedersen, O. D., Rouleau, J.-L., Singh, B. N., Stevenson, L. W., Stevenson, W. G., Thibault, B., & Waldo, A. L.
Affiliations: Montreal Heart Institute (CA)
Libin Cardiovascular Institute of Alberta (CA)
St. Michael's Hospital (CA)
Duke Medical Center (US)
London Health Sciences Centre (CA)
Rhode Island Hospital (US)
St George's Hospital (GB)
Population Health Research Institute (CA)
Goethe University Frankfurt (DE)
Bispebjerg Hospital (DK)
VA West Los Angeles Medical Center (US)
Brigham and Women's Hospital (US)
University Hospitals Cleveland Medical Center (US)
ORCID: Roy, Denis
Talajic, Mario
Nattel, Stanley
Dorian, Paul
Bourassa, Martial G.
Buxton, Alfred E.
Camm, A. John
Connolly, Stuart J.
Ducharme, Anique
Guerra, Peter G.
Hohnloser, Stefan H.
Lambert, Jean
Pedersen, Ole Dyg
Rouleau, Jean-Lucien
Stevenson, Lynne Warner
Stevenson, William G.
Thibault, Bernard
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2008-06-19
Volume: 358
Issue: 25
Pages: 2667-2677
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa0708789
OpenAlex: W2131260805
Cited by: 1,585
References: 41
Citations by year: 2026: 42 · 2025: 33 · 2024: 69 · 2023: 55 · 2022: 76 · 2021: 86 · 2020: 77 · 2019: 82 · 2018: 96 · 2017: 87 · 2016: 73 · 2015: 75 · 2014: 87 · 2013: 123 · 2012: 114
FWCI: 97.76
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: atrial fibrillation, heart failure, rhythm control, rate control, sinus rhythm maintenance, ventricular rate control, cardiovascular mortality, congestive heart failure, stroke, worsening heart failure, left ventricular ejection fraction
MeSH terms: Adrenergic beta-Antagonists, Aged, Amiodarone, Angiotensin-Converting Enzyme Inhibitors, Anti-Arrhythmia Agents, Atrial Fibrillation, Cardiovascular Diseases, Combined Modality Therapy, Digitalis Glycosides, Electric Countershock, Female, Follow-Up Studies, Heart Failure, Heart Rate, Hospitalization, Humans, Male, Middle Aged, Prospective Studies, Ventricular Dysfunction, Left, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks